Klein Lawrence Otto 4
4 · Jade Biosciences, Inc. · Filed May 1, 2025
Insider Transaction Report
Form 4
Klein Lawrence Otto
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-04-29+23,017→ 23,017 totalExercise: $10.14Exp: 2035-04-29→ Common Stock (23,017 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase 23,017 shares of the Issuer's common stock, which vests in full on the earlier of (i) April 29, 2026 or (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the recipient's continued service to the Issuer.